Purpose

The purpose of this study is to compare changes in sleep quality in patients with moderate to severe insomnia, in participants randomized to Cognitive Behavioral Therapy for Insomnia (CBT-I) arm versus those randomized to the SONU Headband Acoustic Resonance Therapy (ART) arm at end of treatment (6 weeks).

Condition

Eligibility

Eligible Ages
Over 22 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult subjects, 22 years of age and older at screening - Moderate-to-severe insomnia disorder, as defined by the International Classification of Sleep Disorders (ICSD-3)* and the Insomnia Severity Index (ISI) and have been diagnosed for more than three months. - Not pregnant by subject self-report at time of consent. - Have the ability to provide informed consent. - Have the ability to complete all aspects of this trial. - Have access to an iOS mobile device (iPhone X or above). - Have no contraindicating comorbid health condition that would interfere with the proper use of the SONU Headband system, as determined by the clinical investigators. - Participants who are taking sleep-aiding pills must agree to no changes to medication and dosage during the study. - According to the third edition of the International Classification of Sleep Disorders (ICSD-3), insomnia is characterized by difficulty in either initiating sleep, maintaining sleep continuity, or poor sleep quality

Exclusion Criteria

  • Patients who are unable to commit to avoiding the consumption of alcohol during the study. - Patients who are unable to commit to avoid consumption of caffeine after 12 pm (noon). - Patients who have a clinically significant or unstable medical or surgical condition. - Participants using pacemakers or cardiac monitors. - Participants with severe physical illness or immediately post-surgery - Participants with severe mental disorders, such as schizophrenia, severe major depression, severe anxiety, bipolar disorder, dementia, substance use disorder, or severe neurological diseases such as a seizure, stroke, or Parkinson's disease. - Participants with other serious sleep disorders, such as severe obstructive sleep apnea. - Participants who are unable to attend regular follow-up evaluations. - Any unstable medical or mental health condition as determined by the physician investigator.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
Randomized clinical trial where subjects are placed into 2 different study arms. Subjects are randomized to 2 groups that either receive acoustic resonance therapy through a wearable device or use cognitive behavioral therapy for insomnia accessed through a learning module.
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
A wearable headband (SONU)
Participants randomized to the SONU Headband arm will receive acoustic resonance therapy (ART) which is delivered through two bone conduction transducers in the headband.
  • Device: Acoustic Resonance Therapy (ART)
    The basis behind the SONU Headband system is acoustic resonance therapy (ART) which is delivered through two bone conduction transducers in the headband. Participants will utilize the SONU headband to receive a 45-minute audio session of the personalized binaural beats audio every evening prior to sleep for a duration of 6 weeks.
    Other names:
    • SONU Headband
Active Comparator
Interactive Modules delivering cognitive behavioral therapy for insomnia
Participants randomized to the CBT-I arm will receive Mayo Clinic Cognitive Behavioral Therapy for Insomnia (CBT-I) learning modules.
  • Behavioral: Mayo Clinic Cognitive Behavioral Therapy for Insomnia (CBT-I)
    The interactive learning module used at Mayo Clinic Cognitive Behavioral Therapy for Insomnia (CBT-I) focuses on five components: - Sleep hygiene - Stimulus control - Sleep restriction - Worry management - Relaxation training The module includes goal-setting prompts, knowledge tests, and informational videos. Participants will utilize the CCBT-I modules daily for 6 weeks.

Recruiting Locations

Mayo Clinic in Rochester
Rochester, Minnesota 55905
Contact:
Stephanie Lindeen, RN
507-293-2470
GIMResearchStudies@mayo.edu

More Details

Status
Recruiting
Sponsor
Mayo Clinic

Study Contact

Stephanie Lindeen, RN
507-7293-2740
GIMResearchStudies@mayo.edu

Detailed Description

This study will randomize 60 participants with moderate to severe Insomnia to one of two treatments over the course of 6 weeks: 1) a wearable device that uses Acoustic Resonance Therapy (ART) or 2) the interactive learning module - Cognitive Behavioral Therapy for Insomnia (CBT-I).

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.